Ask Our Doctors and Nurses!

GABAPENTIN Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

GABAPENTIN Safety Reports

Total GABAPENTIN reports: 347.
GABAPENTIN FDA safety alerts: 2005 .
Reported deaths: 41    Reported hospitalizations: 123.
Take GABAPENTIN Side Effects Survey or Share Your GABAPENTIN Story. Read More Here.

Showing 1-75 of 347 Next >

Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA reported GABAPENTIN problem on May 03, 2007. Female patient, 34 years of age, was diagnosed with epilepsy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: accidental overdose, cerebral atrophy, cerebral ventricle dilatation, coma, status epilepticus. GABAPENTIN dosage: DAILY DOSE:5400MG. During the same period patient was treated with DEPARKIN, SABRIL. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Physician from UNITED STATES on Apr 26, 2007. Male patient, 63 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, delirium tremens, fatigue, hallucination, hyperhidrosis, pyrexia. GABAPENTIN dosage: 4900 MG/DAY. During the same period patient was treated with OXYCODONE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported GABAPENTIN problem on Apr 26, 2007. Male patient, 33 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, delirium tremens, disorientation, hyperhidrosis, hyperreflexia, tachycardia. GABAPENTIN dosage: 3600 MG/DAY. During the same period patient was treated with PAROXETINE, QUETIAPINE FUMARATE, CANNABIS. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from FRANCE on May 02, 2007. Female patient, 67 years of age, was diagnosed with analgesic effect and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, exophthalmos, hyperhidrosis, mood altered, pallor, tremor. GABAPENTIN dosage: 7200 MG;QD. During the same period patient was treated with NAPROXEN, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

Physician from INDONESIA reported GABAPENTIN problem on May 01, 2007. Female patient, 35 years of age, was diagnosed with post herpetic neuralgia, surgery and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: headache, nausea, post herpetic neuralgia, syncope, vomiting. GABAPENTIN dosage: unknown. During the same period patient was treated with ERYTHROMYCIN. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from FRANCE on May 10, 2007. Female patient, 67 years of age, was diagnosed with analgesic effect and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, exophthalmos, hyperhidrosis, overdose, pallor, tremor. GABAPENTIN dosage: unknown. During the same period patient was treated with NAPROXEN, AMITRIPTYLINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on May 22, 2007. Male patient, 47 years of age, weighting 210.0 lb, was diagnosed with analgesic effect and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: depression, partner stress, social problem, suicidal ideation. GABAPENTIN dosage: 900MG 3X DAILY PO. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Female patient, 60 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, hypersensitivity, muscle spasms, myalgia, oedema mouth, swollen tongue. GABAPENTIN dosage: (300 MG), ORAL. During the same period patient was treated with ALPRAZOLAM, ZOLPIDEM TARTRATE, MAXZIDE. Patient recovered.

Pharmacist from UNITED KINGDOM reported GABAPENTIN problem on May 16, 2007. Female patient was diagnosed with convulsion and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral. GABAPENTIN dosage: unknown. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on May 10, 2007. Female patient, 34 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: accidental overdose, cerebral atrophy, cerebral ventricle dilatation, coma, pupil fixed, status epilepticus. GABAPENTIN dosage: 3600 MG, QD, 5400 MG, QD. During the same period patient was treated with DEPARKIN, SABRIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on May 17, 2007. Male patient, 63 years of age, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, delirium tremens, fatigue, hallucination, hyperhidrosis, intentional overdose. GABAPENTIN dosage: unknown. During the same period patient was treated with OXYCODONE. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Physician from UNITED STATES on May 17, 2007. Male patient, 33 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, delirium tremens, disorientation, hyperreflexia, intentional overdose, tachycardia. GABAPENTIN dosage: unknown. During the same period patient was treated with PAROXETINE, QUETIAPINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported GABAPENTIN problem on May 15, 2007. Male patient, 33 years of age, was diagnosed with alcoholism and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, disorientation, hyperhidrosis, hyperreflexia, incorrect dose administered, tachycardia, toxicologic test abnormal. GABAPENTIN dosage: 3600 MG/DAY. During the same period patient was treated with PAROXETINE, QUETIAPINE. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Physician from UNITED STATES on May 15, 2007. Male patient, 63 years of age, was diagnosed with back pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, body temperature increased, confusional state, hallucination, hyperhidrosis, mental status changes, tachycardia, tremor. GABAPENTIN dosage: 4900 MG/DAY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported GABAPENTIN problem on May 15, 2007. Female patient, 67 years of age, was diagnosed with analgesic effect, polyneuropathy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, exophthalmos, hyperhidrosis, pallor, tremor. GABAPENTIN dosage: 4800-7200 MG/DAY. During the same period patient was treated with NAPROXEN, AMITRIPTYLINE, DEXTROPROPOXYPHENE, OXACARBAZEPINE, ALIMEMAZINE, ACEPROMETAZINE. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Pharmacist from UNITED STATES on Feb 23, 2007. Female patient, 56 years of age, was diagnosed with convulsion and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, confusional state, convulsion, disorientation, headache, tremor. GABAPENTIN dosage: 800 MG (800 MG, 1 IN 1 D), ORAL. Patient recovered.

Physician from UNITED KINGDOM reported GABAPENTIN problem on May 17, 2007. Male patient, 75 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: choreoathetosis, dyskinesia. GABAPENTIN dosage: 200 MG, TID. During the same period patient was treated with CARBIDOPA, LEVODOPA, ENTACAPONE. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2007. Male patient was diagnosed with nerve injury and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: suicide attempt. GABAPENTIN dosage: unknown. Patient recovered.

Consumer or non-health professional from FRANCE reported GABAPENTIN problem on May 21, 2007. Female patient, 67 years of age, was diagnosed with analgesic effect and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, exophthalmos, hyperhidrosis, overdose, pallor, tremor. GABAPENTIN dosage: unknown. During the same period patient was treated with NAPROXEN, AMITRIPTYLINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Physician from TUNISIA on May 23, 2007. Male patient, 56 years of age, was diagnosed with formication and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: asthenia, erectile dysfunction. GABAPENTIN dosage: DAILY DOSE:900MG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on June 01, 2007. Male patient, 42 years of age, weighting 203.0 lb, was diagnosed with glossopharyngeal neuralgia, pain management, trigeminal neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dupuytren's contracture, hypoaesthesia, muscle twitching, paraesthesia, rash erythematous. GABAPENTIN dosage: unknown. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on May 24, 2007. Male patient, 64 years of age, weighting 207.2 lb, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: blood pressure fluctuation, memory impairment, road traffic accident, syncope. GABAPENTIN dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, BISOPROLOL FUMARATE, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, LISINOPRIL, SIMVASTATIN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported GABAPENTIN problem on May 23, 2007. Male patient, 64 years of age, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, blood pressure fluctuation, dizziness, hypertension, hypotension, memory impairment, road traffic accident, syncope. GABAPENTIN dosage: 600 MG; QID; PO. During the same period patient was treated with LISINOPRIL, ACETYLSALICYLIC ACID SRT, SIMVASTATIN, LANSOPRAZOLE, BISOPROLOL FUMARATE, ISOSORBIDE MONONITRATE. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from FRANCE on May 31, 2007. Female patient, 53 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. GABAPENTIN dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, LYRICA, METFORMIN, OMEPRAZOLE, QUININE SULPHATE, CLONAZEPAM, THIAMINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported GABAPENTIN problem on May 25, 2007. Male patient, 53 years of age, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, headache. GABAPENTIN dosage: 300 MG, UNK, ORAL. During the same period patient was treated with IBUPROFEN. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on May 23, 2007. Male patient, 64 years of age, weighting 207.2 lb, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, blood pressure fluctuation, memory impairment, road traffic accident, syncope. GABAPENTIN dosage: 600 MG, QID, ORAL. During the same period patient was treated with ASPIRIN, BISOPROLOL FUMARATE, ELANTAN LA, LANSOPRAZOLE, LISINOPRIL, SIMVASTATIN. Patient recovered.

Health Professional from UNITED KINGDOM reported GABAPENTIN problem on May 24, 2007. Female patient, 66 years of age, was diagnosed with abdominal pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: metastases to lung, metastatic neoplasm, ovarian cancer. GABAPENTIN dosage: 600 MG, TID, ORAL. Patient died.

GABAPENTIN problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on June 05, 2007. Female patient, 34 years of age, was diagnosed with epilepsy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: accidental overdose, areflexia, cerebral atrophy, cerebral ventricle dilatation, convulsion, muscle twitching, status epilepticus. GABAPENTIN dosage: 5400 MG, QD;. During the same period patient was treated with DEPARKIN, SABRIL. Patient was hospitalized. Patient recovered.

Physician from SPAIN reported GABAPENTIN problem on May 28, 2007. Female patient, 74 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, depressed level of consciousness, hypersomnia, hypoventilation, respiratory depression. GABAPENTIN dosage: unknown. During the same period patient was treated with IPRATROPIUM BROMIDE, SALMETEROL, FLUTICASONE PROPIONATE. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Male patient, 33 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, disorientation, hyperhidrosis, hyperreflexia, tachycardia, tremor. GABAPENTIN dosage: DAILY DOSE:3600MG. During the same period patient was treated with PAROXETINE, QUETIAPINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported GABAPENTIN problem on June 04, 2007. Female patient, 88 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia, mania, paranoia. GABAPENTIN dosage: unknown. During the same period patient was treated with RANITIDINE, BENDROFLUMETHIAZIDE, DICLOFENAC, DOMPERIDONE, LEVOTHYROXINE, MOVICOL, OXYCONTIN. Patient was hospitalized and became disabled. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from TURKEY on June 06, 2007. Female patient, 35 years of age, was diagnosed with pain in extremity, neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: breast mass, carcinoembryonic antigen increased. GABAPENTIN dosage: unknown. During the same period patient was treated with PREGABALIN, TRAMADOL, DIAZEPAM, DICLOFENAC. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported GABAPENTIN problem on June 01, 2007. Female patient, 68 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia, coordination abnormal, mania, paranoia. GABAPENTIN dosage: unknown. During the same period patient was treated with RANITIDINE, BENDROFLUMETHIAZIDE. Patient was hospitalized and became disabled. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on June 01, 2007. Female patient, 86 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia, mania, paranoia. GABAPENTIN dosage: unknown. During the same period patient was treated with RANITIDINE, BENDROFLUMETHIAZIDE, DICLOFENAC, DOMPERIDONE, LEVOTHYROXINE, MOVICOL, OXYCONTIN. Patient was hospitalized and became disabled. Patient recovered.

Pharmacist from UNITED STATES reported GABAPENTIN problem on June 20, 2007. Female patient, 38 years of age, was diagnosed with neuralgia, pain in extremity, procedural pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dizziness, tinnitus. GABAPENTIN dosage: unknown. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on June 07, 2007. Female patient was diagnosed with convulsion and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, neuropathy peripheral. GABAPENTIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported GABAPENTIN problem on June 12, 2007. Male patient, 75 years of age, was diagnosed with neuralgia, parkinson's disease and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: choreoathetosis, dyskinesia, lumbar spinal stenosis. GABAPENTIN dosage: unknown. During the same period patient was treated with ENTACAPONE, CARBIDOPA, LEVODOPA. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2007. Female patient, 45 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: gastric disorder, nausea, pain. GABAPENTIN dosage: unknown. Patient recovered.

Physician from SPAIN reported GABAPENTIN problem on June 08, 2007. Female patient, 74 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, depressed level of consciousness, hypersomnia, hypoventilation, poor quality sleep, respiratory depression. GABAPENTIN dosage: unknown. During the same period patient was treated with IPRATROPIUM BROMIDE, SALMETEROL, FLUTICASONE, CORTICOSTEROIDS, LEVOFLOXACIN. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 08, 2007. Female patient, 63 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: jaundice. GABAPENTIN dosage: 100 MG; BID. During the same period patient was treated with PREGABALIN, SIMVASTATIN, OXYBUTYNIN, BACLOFEN. Patient recovered.

Health Professional from UNITED KINGDOM reported GABAPENTIN problem on June 14, 2007. Female patient, 55 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dystonia, myotonia. GABAPENTIN dosage: unknown. During the same period patient was treated with SEVOFLURANE, CODEINE SUL, DEXAMETHASONE, FENTANYL, OXYGEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on June 08, 2007. Female patient, 63 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: jaundice. GABAPENTIN dosage: unknown. During the same period patient was treated with LYRICA, BACLOFEN, OXYBUTYNIN, SIMVASTATIN. Patient recovered.

Health Professional from UNITED KINGDOM reported GABAPENTIN problem on June 13, 2007. Female patient, 55 years of age, weighting 132.3 lb, was diagnosed with neuralgia, osteotomy, varicose vein operation and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dystonia, myotonia, sinus tachycardia. GABAPENTIN dosage: 600 MG, TID. During the same period patient was treated with ALFENTANIL, FENTANYL, PROPOFOL, ISOFLURANE, SEVOFLURANE. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 15, 2007. Male patient, 76 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, parkinson's disease. GABAPENTIN dosage: 100 MG; TID; PO. During the same period patient was treated with FELODIPINE, LEVODOPA W. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported GABAPENTIN problem on June 15, 2007. Female patient, 64 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: alopecia, appendicitis perforated, surgery. GABAPENTIN dosage: unknown. During the same period patient was treated with TRIMIPRAMINE MALEATE, HORMONES. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 15, 2007. Male patient, 76 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, parkinson's disease. GABAPENTIN dosage: 100 MG, TID, ORAL. During the same period patient was treated with FELODIPINE, MADOPAR CR. Patient recovered.

Health Professional from UNITED KINGDOM reported GABAPENTIN problem on June 18, 2007. Male patient, 76 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: parkinson's disease. GABAPENTIN dosage: unknown. During the same period patient was treated with FELODIPINE, MADOPAR. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UKRAINE on June 18, 2007. Female patient, weighting 125.7 lb, was diagnosed with diabetic neuropathy, pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: brain contusion, lower limb fracture, mental disorder, suicide attempt. GABAPENTIN dosage: unknown. During the same period patient was treated with ALPHA LIPOIC ACID, MILGAMMA, NOVORAPID, LANTUS. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported GABAPENTIN problem on June 18, 2007. Male patient, 76 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, parkinson's disease. GABAPENTIN dosage: 300 MG (100 MG, 3 IN 1 D). Patient recovered.

GABAPENTIN problem was reported by a Physician from TURKEY on June 23, 2006. Female patient, 69 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, gastroenteritis, loss of consciousness, myoclonus, paraesthesia. GABAPENTIN dosage: 900 MG (1 D), ORAL. During the same period patient was treated with AMITRIPTYLINE, CANDESARTAN CILEXETIL, DEXAMETHASONE, TRAMADOL. Patient died on 06/01/2006.

Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on June 23, 2006. Female patient, weighting 154.0 lb, was diagnosed with neuropathy peripheral and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: poor peripheral circulation. GABAPENTIN dosage: 1600 MG (800 MG, 2 IN 1 D). During the same period patient was treated with CAMPRAL, PROMETRIUM, NITROFURAN. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on June 26, 2006. Female patient, 29 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: fall, sensory loss, thermal burn. GABAPENTIN dosage: 800 MG, TID, ORAL. During the same period patient was treated with CLONAZEPAM. Patient recovered.

Pharmacist from UNITED STATES reported GABAPENTIN problem on July 13, 2006. Male patient, weighting 216.0 lb, was diagnosed with neuropathy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: nocturia. GABAPENTIN dosage: unknown. Patient recovered.

GABAPENTIN problem was reported by a Physician from TURKEY on July 06, 2006. Female patient, 69 years of age, was diagnosed with trigeminal neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, gastroenteritis, loss of consciousness, myoclonus, paraesthesia, somnolence. GABAPENTIN dosage: 900 MG (300 MG, 3 IN 1 D), ORAL. During the same period patient was treated with AMITRIPTYLINE, CANDESARTAN CILEXETIL, DEXAMETHASONE, TRAMADOL. Patient died on 06/01/2006.

Health Professional from UNITED KINGDOM reported GABAPENTIN problem on July 12, 2006. Female patient, 66 years of age, was diagnosed with abdominal pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, metastatic neoplasm, visual acuity reduced transiently. GABAPENTIN dosage: 18900 MG (600 MG, 3 IN 1 D), ORAL. Patient died.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2006. Male patient, 47 years of age, weighting 157.0 lb, was diagnosed with neuropathy peripheral and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: morbid thoughts, personality change, suicidal ideation. GABAPENTIN dosage: 3000MG PER DAY PO. Patient recovered.

Physician from UNITED STATES reported GABAPENTIN problem on July 27, 2006. Male patient, weighting 156.0 lb, was diagnosed with neuropathy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: mental status changes. GABAPENTIN dosage: 400 MG DAILY BUCCAL. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from GERMANY on July 03, 2006. Male patient, 66 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: abasia, areflexia, blood creatinine increased, blood urea increased, dysarthria, dyskinesia, dysstasia, extensor plantar response. GABAPENTIN dosage: 900 MG, SINGLE,. Patient recovered.

Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on Aug 02, 2006. Male patient, 64 years of age, weighting 193.0 lb, was diagnosed with neuropathy peripheral and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling abnormal. GABAPENTIN dosage: 800 MG TID [LIFETIME]. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Female patient, 61 years of age, weighting 150.0 lb, was diagnosed with complex regional pain syndrome and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: aspiration, cardiac disorder, complex regional pain syndrome, condition aggravated, dyspnoea, fall, foot fracture, nausea, vomiting. GABAPENTIN dosage: 1200 MG (600 MG, 2 IN 1 D),. During the same period patient was treated with DARVOCET. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported GABAPENTIN problem on July 24, 2006. Female patient, 21 years of age, weighting 92.59 lb, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: catatonia, delusion, hallucination, auditory, psychotic disorder, stereotypy, stupor. GABAPENTIN dosage: 2.4 GRAM (300 MG,8 IN 1 D), ORAL. During the same period patient was treated with MEFENAMIC ACID. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Physician from TURKEY on Aug 02, 2006. Female patient, 69 years of age, was diagnosed with trigeminal neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, gastroenteritis, loss of consciousness, myoclonus, paraesthesia, somnolence. GABAPENTIN dosage: 900 MG (300 MG, 3 IN 1 D), ORAL. During the same period patient was treated with AMITRIPTYLINE, CANDESARTAN CILEXETIL, DEXAMETHASONE, TRAMADOL, HYDROCHLOROTHIAZIDE. Patient died on 06/22/2006.

Health Professional from UNITED STATES reported GABAPENTIN problem on Aug 15, 2006. Female patient, 55 years of age, weighting 155.0 lb, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. GABAPENTIN dosage: unknown. Patient recovered.

GABAPENTIN problem was reported by a Pharmacist from UNITED STATES on Aug 17, 2006. Male patient, weighting 500.4 lb, was diagnosed with neuropathy peripheral, polyneuropathy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, anxiety disorder, nightmare. GABAPENTIN dosage: 300 MG TID PO. During the same period patient was treated with ALBUTEROL SULPHATE AND IPRATROPIUM BROMIDE, CALCIUM 250MG, DARBEPOETIN ALFA, LANOXIN, DULOXETINE, FELODIPINE. Patient recovered.

Physician from TURKEY reported GABAPENTIN problem on Aug 08, 2006. Female patient was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dark circles under eyes, loss of consciousness, somatisation disorder. GABAPENTIN dosage: 900 MG 300 MG, 3 IN 1 D), ORAL. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from DENMARK on Aug 04, 2006. Female patient, 29 years of age, was diagnosed with epilepsy, neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: fall, sensory loss, thermal burn, unresponsive to stimuli. GABAPENTIN dosage: 800 MG;TID;PO. During the same period patient was treated with CLONAZEPAM. Patient recovered.

Consumer or non-health professional from DENMARK reported GABAPENTIN problem on Aug 04, 2006. Female patient, 71 years of age, was diagnosed with diabetic neuropathy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, off label use. GABAPENTIN dosage: 300 MG;TID;PO. During the same period patient was treated with ASPIRIN, CLONIDINE, FOLIC ACID, FUROSEMIDE, GLICLAZIDE, LEVOTHYROXINE, METFORMIN, SIMVASTATIN. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on Aug 07, 2006. Female patient, 66 years of age, weighting 154.3 lb, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: depression, dizziness, hyperhidrosis, sleep disorder, suicidal ideation. GABAPENTIN dosage: unknown. During the same period patient was treated with PREGABALIN, AZITHROMYCIN, BENDROFLUAZIDE, CODEINE, LATANOPROST, ACETAMINOPHEN. Patient recovered.

Health Professional from UNITED KINGDOM reported GABAPENTIN problem on Aug 15, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: blood electrolytes abnormal, blood urea abnormal, confusional state, therapeutic agent toxicity. GABAPENTIN dosage: 600 MG (200 MG, 3 IN 1 D), ORAL. During the same period patient was treated with SPIRONOLACTONE, DIGOXIN, CETIRIZINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 10, 2006. Female patient, 16 years of age, was diagnosed with epilepsy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: aggression. GABAPENTIN dosage: (300 MG). During the same period patient was treated with EPILIM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on Aug 14, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: blood electrolytes abnormal, blood urea abnormal, confusional state, therapeutic agent toxicity. GABAPENTIN dosage: 600 MLLIGRAM, ORAL. During the same period patient was treated with SPIRONOLACTONE, DIGOXIN, CETIRIZINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.

GABAPENTIN problem was reported by a Physician from UNITED KINGDOM on Aug 16, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: blood electrolytes abnormal, blood urea abnormal, confusional state, therapeutic agent toxicity. GABAPENTIN dosage: 200 MG, TID, ORAL. During the same period patient was treated with DIGOXIN, SPIRONOLACTONE, CETIRIZINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported GABAPENTIN problem on Aug 08, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: muscle twitching, swelling. GABAPENTIN dosage: unknown. During the same period patient was treated with LYRICA. Patient recovered.

GABAPENTIN problem was reported by a Health Professional from UNITED STATES on Aug 30, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: no therapeutic response. GABAPENTIN dosage: 800MG TID PO. Patient recovered.

Health Professional from UNITED KINGDOM reported GABAPENTIN problem on Aug 22, 2006. Female patient, 60 years of age, weighting 154.3 lb, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: joint swelling. GABAPENTIN dosage: 900 MG (300 MG, 3 IN 1 D), ORAL. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.

Showing 1-75 of 347 Next >